Stem Cell treatment research:

Here we have a stem cell research paper library for you to learn more about stem cells and how they are being used in treatments today:

Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrowow:

Human umbilical cord perivascular cells (HUCPVCs) have been shown to have a high proliferative potential and the capacity to differentiate into an osteogenic phenotype. HUCPVCs have thus been considered a possible extra-embryonic mesenchymal stem cell (MSC) source for cell-based therapies. To assess this potential, we compared HUCPVCs to the “gold standard” bone marrow mesenchymal stromal cells (BMSCs) with respect to their proliferation, differentiation, and transfection capacities. HUCPVCs showed a higher proliferative potential than BMSCs and were capable of osteogenic, chondrogenic, and adipogenic differentiation.

Click here to view or download the research paper

Human Umbilical Cord Blood as a Source of Transplantable Heptic Progenitor cells:

Human umbilical cord blood (UBC) cells have advantages as grafts for cell transplantation because of the immaturity of new born cells compared with adult cells. In contrast to their hematopoietic and mesenchymal potential, it remains unclear wether UCB cells have endodermal competence. Here, with a view to utilize UCB cells for cell transplantationinto injured liver, we investigated the hepatic potential of UCB cells both in vitro and in vivo.

Click here to view or download the research paper

Cord blood stem cell transplantation:

The transplantation of blood-forming stem cells is an accepted treatment to restore the body’s ability to make blood and immune cells. Blood-forming or “hematopoietic” stem cells (HSCs) can develop into any of the three types of blood cells: red cells, white cells or platelets.

Click here to view or download the research paper

Human Umbilical Cord Blood-derived Mesencymal Stem Cell Therapy for Stroke:

Mesenchymal stem cells(MSCs) have the ability to differentiate into multiple cell types. It has been reported that MSCs ameliorate functional deficits after transplantation into various neurologic disease models. In this study, to demonstrate the effect of human umbilical cord blood-derived MSCs(hUCB-MSCs) on stroke models, we transplanted the PKH-26 labeled hUCB-MSCs into the contralateral region of injured rat brain at 7 days after injury, and then examined the behavioral test, migration ability of transplanted hUCB-MSCs to injury site, and differentiation potentiality of transplanted hUCB-MSCs into neural cells.

Click here to view or download the research paper

Umbilical cord blood transplantation in human:

Human cord and placental blood provides a rich source of hematopoietic stem cells. On the basis of the finding, umbilical cord blood stem cells have been used to reconstitute hematopoiesis in children with malignant and non malignant diseases after treatment with myeloablative doses of chemoradiotherapy. Early results show, that a single cord blood provides enough hematopoietic stem cells to provide short and long term engraftment and, that the incidence and severity of graft versus host disease has been low even in HLA mismatched transplants.

Click here to view or download the research paper

Cord Blood CD34+ Cells Have A Thousand-Fold Higher Capacity For Generating Progenitors In Vitro Than G1 CD34+:

We examined the functional differences between G0 and G1 cord blood CD34+ cells for up to 24 weeks in serum-free suspension culture, containing Flt-3 ligand, thrombopoietin and stem cell factor. By week 24, there is more than a 1,000-fold difference in granulocyte, macrophage-colony-forming cells (GM-CFC) cumulative production between the two populations, with cultures initiated from G0 demonstrating an amplification of 1.1 × 105-1.8 × 106 of GM-CFC compared to 45-2.7 × 103 for the G1 cells.

Click here to view or download the research paper

Biology of Human Umbilical Cord Blood-Derived Hematopoietic Stem/Progenitor Cells:

Reported in 1989, studies by Broxmeyer, Gluckman, and colleagues demonstrated that umbilical cord blood (UCB) is a rich source of hematopoietic stem/progenitor cells (HSPC) and that UCB could be used in clinical settings for hematopoietic cell transplantation. Since then, angreat interest has been generated on the biological characterization of these cells.

Click here to view or download the research paper

The Significant Cardiomyogenic Potential of Human Umbilical Cord:

We tested the cardiomyogenic potential of the human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). Both the number and function of stem cells may be depressed in senile patients with severe coronary risk factors. Therefore, stem cells obtained from such patients may not function well. For this reason, UCBMSCs are potentially a new cell source for stem cell-based therapy, since such cells can be obtained from younger populations and are being routinely utilized for clinical patients.

Click here to view or download the research paper

Human Umbilical Cord Blood Cells Differentiate into Muscle in sjl Muscular Dystrophy:

Limb girdle muscular dystrophy type 2B form (LGMD- 2B) and Miyoshi myopathy (MM) are both caused by mutations in the dysferlin (dysf) gene. In this study, we used dysferlin-deficient sjl mice as a mouse model to study cell therapy for LGMD-2B and MM. A single-blind study evaluated the therapeutic potential of human umbilical cord blood (HUCB) as a source of myogenic progenitor stem cells.

Click here to view or download the research paper

Human Umbilical Cord Blood Progenitors:
The Potential of These Hematopoietic Cells to Become Neural:

The mononuclear fraction from human umbilical cord blood (HUCB) contains a significant number of stem/progenitor cells that in theory could become any cell in the body, including neurons. Taking into consideration that transdifferentiation would be a very rare event and also knowing that overlapping genetic programs for hematopoiesis and neuropoiesis exist, we undertook a characterization of the HUCB mononuclear fraction, including analysis of cellular subpopulations and their morphology, cell viability, proliferation, and expression of neural and hematopoietic antigens.

Click here to view or download the research paper

 

Condition specific stem cell research papers: